Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
Status:
NOT_YET_RECRUITING
Trial end date:
2031-12-01
Target enrollment:
Participant gender:
Summary
single-center, randomized, double-blind, placebo-controlled Phase 2 study to evaluate safety and efficacy of overnight metyrapone in patients with MACS.